Novavax (NVAX) PT Lowered to $1.25 at Citi; Maintains Buy on 3 Upside Opportunities
Tweet Send to a Friend
Citi analyst Joel Beatty lowered the price target on Novavax (NASDAQ: NVAX) to $1.25 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
